RecruitingNot ApplicableNCT05680012

Tissue Destruction and Healing in Celiac Disease


Sponsor

University of Chicago

Enrollment

220 participants

Start Date

Jul 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this clinical study is to learn more about celiac disease pathogenesis and clinical symptoms. In particular, this study will examine the interactions between biological factors such as, intestinal epithelial cells, microbiota, immune system, genetics, and gluten and their effect on celiac disease clinical symptoms, and severity of tissue destruction and its ability to heal in individuals with celiac disease. Information collected in the study will help researchers to generate better resources to advance celiac disease patient care.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Gluten containing snack bar for people with celiac disease. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTGluten containing snack bar

Ingest snack bars containing 3 grams of gluten every day for 6 weeks.


Locations(3)

California Institute of Technology

Pasadena, California, United States

The University of Chicago

Chicago, Illinois, United States

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05680012


Related Trials